MC

534.2

-1.71%↓

SANES

5.485

-9.22%↓

BNP

68.43

-7.5%↓

CS.FR

37.54

-5.3%↓

ALV

334.5

-5.43%↓

MC

534.2

-1.71%↓

SANES

5.485

-9.22%↓

BNP

68.43

-7.5%↓

CS.FR

37.54

-5.3%↓

ALV

334.5

-5.43%↓

MC

534.2

-1.71%↓

SANES

5.485

-9.22%↓

BNP

68.43

-7.5%↓

CS.FR

37.54

-5.3%↓

ALV

334.5

-5.43%↓

MC

534.2

-1.71%↓

SANES

5.485

-9.22%↓

BNP

68.43

-7.5%↓

CS.FR

37.54

-5.3%↓

ALV

334.5

-5.43%↓

MC

534.2

-1.71%↓

SANES

5.485

-9.22%↓

BNP

68.43

-7.5%↓

CS.FR

37.54

-5.3%↓

ALV

334.5

-5.43%↓

Search

Eurazeo SE

Închisă

SectorFinanțe

59.7 -5.91

Rezumat

Modificarea prețului

24h

Curent

Minim

58.8

Maxim

59.75

Indicatori cheie

By Trading Economics

Venit

-105M

Vânzări

104M

Randament dividend

3.89

Marjă de profit

-100.723

EBITDA

-51M

Recomandări

By TipRanks

Recomandări

Cumpărare

Prognoză pe 12 luni

+57.6% upside

Dividende

By Dow Jones

Randament dividend

Medie Sector

3.89%

3.90%

Următoarele câștiguri

10 apr. 2025

Statistici piață

By TradingEconomics

Capitalizare de piață

5.1B

Deschiderea anterioară

65.61

Închiderea anterioară

59.7

Sentimentul știrilor

By Acuity

41%

59%

163 / 542 Clasament în Finance

Scor tehnic

By Trading Central

Încredere

Very Strong Bearish Evidence

Eurazeo SE Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

11 sept. 2024, 06:28 UTC

Achiziții, Fuziuni, Preluări

EQT Leads $102.5 Million Series A Funding Round in Belgian Radioisotope Producer PanTera

Comparație

Modificare preț

Eurazeo SE Așteptări

Obiectiv de preț

By TipRanks

57.6% sus

Prognoză pe 12 luni

Medie 100 EUR  57.6%

Maxim 100 EUR

Minim 100 EUR

În baza a 1 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruEurazeo SE - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Cumpărare

1 ratings

1

Cumpărare

0

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

N/A / 71.1Suport & Rezistență

Termen scurt

Very Strong Bearish Evidence

Termen mediu

Bearish Evidence

Termen lung

Strong Bearish Evidence

Sentiment

By Acuity

163 / 542 Clasament în Finanțe

Sentimentul știrilor

Evidențe de creștere

Volatilitate

Sub medie

Volumul știrilor (RCV)

Sub medie

Date financiare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Eurazeo SE

Eurazeo SE is a private equity and venture capital firm specializing in growth capital, acquisitions, leveraged buyouts, and buy-ins of a private company, and investments in mid-market and listed public companies. The company invest in equity in the small-mid and Mid-large buyout segments. The firm seeks to invest in medium-sized or large companies, SMEs, high growth companies, and real estate management and investment activities. It does not have any restrictions regarding the sectors in which it invests but prefers to invest in smart cities, services, leisure and mobility, real estate, fintech, investment activities, distribution, industry, luxury, consumer goods, business services, consumer and retail brands, and health sectors. The firm seeks to invest in consumer brands with a focus on beauty, personal care, household care, juvenile products, apparel, wellness, accessories, home, jewellery, leisure, health, fitness, beverage, and food companies based in United States and Europe. It typically invests in companies with a differentiated concept and global growth potential. The firm identifies companies upstream, carefully selecting them primarily from sectors driven by digital transformation and focusing on changes in lifestyle and consumption (mobility, online buying, collaboration models, etc. The firm invests in large properties in need of restructuring; residential, commercial, and office development projects; and companies with real estate assets in Western Europe. It primarily invests in United States, France, Italy, North America and other European countries. It seeks to invest between "50 million ($54.35 million) to "250 million ($271.77 million) in small mid buyout business. It seeks to invest between "25 million ($27.18 million) to "100 million ($108.71 million) in growth business. It seeks to invest between "10 million ($10.82 million) and "40 million ($43.82 million) in the fields of healthcare research. It seeks to invests between equity investment between "1 million ($1.17 million) and "559.01 mil